Last reviewed · How we verify

N-acetyl-5-methoxytryptamine

University of Baghdad · Phase 3 active Small molecule

N-acetyl-5-methoxytryptamine (melatonin) acts as a melatonin receptor agonist to regulate circadian rhythms and provide antioxidant and anti-inflammatory effects.

N-acetyl-5-methoxytryptamine (melatonin) acts as a melatonin receptor agonist to regulate circadian rhythms and provide antioxidant and anti-inflammatory effects. Used for Circadian rhythm sleep disorders, Insomnia.

At a glance

Generic nameN-acetyl-5-methoxytryptamine
Also known asMelatonin powder
SponsorUniversity of Baghdad
Drug classMelatonin receptor agonist
TargetMT1 and MT2 melatonin receptors
ModalitySmall molecule
Therapeutic areaNeurology; Sleep disorders
PhasePhase 3

Mechanism of action

This compound is a derivative of melatonin, the endogenous hormone produced by the pineal gland that regulates sleep-wake cycles. It binds to melatonin receptors (MT1 and MT2) in the suprachiasmatic nucleus and peripheral tissues, restoring circadian rhythm function. Additionally, it exerts direct free radical scavenging and mitochondrial antioxidant properties independent of receptor binding.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results